CCR2 and neoplasm: Animal experiments show that CCL2 is blocked-the CCR2 axis is greatly reduced by hindering TAMs recruitment to increase the incidence of tumors, thereby enhancing the anti-tumor efficacy of CD8 (+) T cells in the TME 76.